A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 171 participants.
Also called NCT01505426
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 171 participants
- Sponsor
- Registry
-
NCT01505426
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea, Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT01505426. Randomized; quadruple masking; primary purpose treatment. Start 2011-11-28 (actual); primary completion 2013-01-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients
- Condition
- Type II Diabetes Mellitus
- Intervention (Drug)
- ASP1941
- Intervention (Drug)
- metformin
- Intervention (Drug)
- Placebo
- Lead sponsor
- Astellas Pharma Inc
Record details
- Record id
cardio:ct-nct01505426- Content hash
c6e156bffb216ffe4312cddf586a5a6200b246abec037607a5adf82c811bfda0